MGNX – Macrogenics Inc
MacroGenics, Inc.MGNX
$1.56Name : MacroGenics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $98,105,416.00
EPSttm : -1.07
MacroGenics, Inc.
$1.56
0.97%$0.015Float Short %
9.79
Margin Of Safety %
Put/Call OI Ratio
1.07
EPS Next Q Diff
-0.46
EPS Last/This Y
-1.82
EPS This/Next Y
2.89
Price
1.54
Target Price
6
Analyst Recom
2.57
Performance Q
-35.83
Relative Volume
0.74
Beta
1.73
Ticker: MGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | MGNX | 1.275 | 1.22 | 999.99 | 3664 |
| 2025-04-15 | MGNX | 1.27 | 1.22 | 999.99 | 3664 |
| 2025-04-16 | MGNX | 1.185 | 1.22 | 999.99 | 3664 |
| 2025-04-17 | MGNX | 1.28 | 1.22 | 999.99 | 3664 |
| 2025-04-18 | MGNX | 1.26 | 1.22 | 999.99 | 3664 |
| 2025-04-21 | MGNX | 1.4 | 1.08 | 2.48 | 1908 |
| 2025-04-22 | MGNX | 1.535 | 1.11 | 0.00 | 1988 |
| 2025-04-23 | MGNX | 1.705 | 1.11 | 0.00 | 1993 |
| 2025-04-24 | MGNX | 1.79 | 1.08 | 0.00 | 2016 |
| 2025-04-25 | MGNX | 1.71 | 1.0575176589304 | 0.1 | 2039 |
| 2025-04-28 | MGNX | 1.64 | 1.048 | 0.2 | 2048 |
| 2025-04-29 | MGNX | 1.61 | 1.05 | 6.00 | 2051 |
| 2025-04-30 | MGNX | 1.735 | 1.08 | 0.00 | 2080 |
| 2025-05-01 | MGNX | 1.69 | 1.07 | 2.50 | 2088 |
| 2025-05-02 | MGNX | 1.76 | 1.08 | 0.00 | 2097 |
| 2025-05-05 | MGNX | 1.635 | 1.06 | 0.00 | 2112 |
| 2025-05-06 | MGNX | 1.47 | 1.06 | 25.00 | 2120 |
| 2025-05-07 | MGNX | 1.49 | 1.06 | 25.00 | 2120 |
| 2025-05-08 | MGNX | 1.535 | 1.10 | 0.00 | 2170 |
| 2025-05-09 | MGNX | 1.425 | 1.10 | 0.00 | 2170 |
| 2025-05-12 | MGNX | 1.59 | 1.08 | 0.00 | 2198 |
| 2025-05-13 | MGNX | 1.56 | 1.07 | 0.95 | 2211 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | MGNX | 1.27 | 17.9 | - | -2.89 |
| 2025-04-15 | MGNX | 1.26 | 17.9 | - | -2.89 |
| 2025-04-16 | MGNX | 1.18 | 17.9 | - | -2.89 |
| 2025-04-17 | MGNX | 1.26 | 17.9 | - | -2.89 |
| 2025-04-18 | MGNX | 1.26 | 17.9 | - | -2.89 |
| 2025-04-21 | MGNX | 1.40 | 17.9 | - | -2.89 |
| 2025-04-22 | MGNX | 1.52 | 17.9 | - | -2.89 |
| 2025-04-23 | MGNX | 1.71 | 17.9 | - | -2.89 |
| 2025-04-24 | MGNX | 1.78 | 17.9 | - | -2.89 |
| 2025-04-25 | MGNX | 1.71 | 17.9 | - | -2.89 |
| 2025-04-28 | MGNX | 1.64 | 17.9 | - | -2.89 |
| 2025-04-29 | MGNX | 1.60 | 17.9 | - | -2.89 |
| 2025-04-30 | MGNX | 1.74 | 17.9 | - | -2.89 |
| 2025-05-01 | MGNX | 1.68 | 17.9 | - | -2.89 |
| 2025-05-02 | MGNX | 1.75 | 17.9 | - | -2.89 |
| 2025-05-05 | MGNX | 1.64 | 17.9 | - | -2.89 |
| 2025-05-06 | MGNX | 1.48 | 17.9 | - | -2.89 |
| 2025-05-07 | MGNX | 1.49 | 17.9 | - | -2.89 |
| 2025-05-08 | MGNX | 1.53 | 17.9 | - | -2.89 |
| 2025-05-09 | MGNX | 1.43 | 17.9 | - | -2.89 |
| 2025-05-12 | MGNX | 1.59 | 17.9 | - | -2.89 |
| 2025-05-13 | MGNX | 1.54 | 17.9 | - | -2.89 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | MGNX | -0.01 | -4.98 | 9.69 |
| 2025-04-15 | MGNX | -0.01 | -4.98 | 9.69 |
| 2025-04-16 | MGNX | -0.01 | -4.98 | 9.69 |
| 2025-04-17 | MGNX | -0.01 | -4.98 | 9.69 |
| 2025-04-18 | MGNX | -0.01 | -4.98 | 9.69 |
| 2025-04-21 | MGNX | -0.01 | -5.09 | 9.69 |
| 2025-04-22 | MGNX | -0.01 | -5.09 | 9.69 |
| 2025-04-23 | MGNX | -0.01 | -5.09 | 9.69 |
| 2025-04-24 | MGNX | -0.01 | -5.09 | 9.69 |
| 2025-04-25 | MGNX | -0.01 | -5.09 | 9.69 |
| 2025-04-28 | MGNX | -0.01 | -6.10 | 9.20 |
| 2025-04-29 | MGNX | -0.01 | -6.10 | 9.20 |
| 2025-04-30 | MGNX | -0.01 | -6.10 | 9.20 |
| 2025-05-01 | MGNX | -0.01 | -6.10 | 9.20 |
| 2025-05-02 | MGNX | -0.01 | -6.10 | 9.20 |
| 2025-05-05 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-06 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-07 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-08 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-09 | MGNX | -0.01 | -0.95 | 9.20 |
| 2025-05-12 | MGNX | -0.01 | -0.22 | 9.79 |
| 2025-05-13 | MGNX | -0.01 | -0.22 | 9.79 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.25
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.71
Insider Transactions
-0.01
Institutional Transactions
-0.22
Beta
1.73
Average Sales Estimate Current Quarter
9
Average Sales Estimate Next Quarter
11
Fair Value
Quality Score
43
Growth Score
50
Sentiment Score
35
Actual DrawDown %
95.8
Max Drawdown 5-Year %
-97
Target Price
6
P/E
Forward P/E
PEG
P/S
0.65
P/B
0.83
P/Free Cash Flow
EPS
-1.07
Average EPS Est. Cur. Y
-2.89
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-44.66
Relative Volume
0.74
Return on Equity vs Sector %
-81.4
Return on Equity vs Industry %
-64.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MacroGenics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading